Growth Metrics

Cytosorbents (CTSO) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 66.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 66.18%
Dec 31, 2025 -104.69%
Sep 30, 2025 0.80%
Jun 30, 2025 67.87%
Mar 31, 2025 28.86%
Dec 31, 2024 62.94%
Sep 30, 2024 51.11%
Jun 30, 2024 33.48%
Mar 31, 2024 -56.84%
Dec 31, 2023 41.66%
Sep 30, 2023 -200.26%
Jun 30, 2023 35.06%
Mar 31, 2023 69.69%
Dec 31, 2022 -22.05%
Sep 30, 2022 38.92%
Jun 30, 2022 -294.31%
Mar 31, 2022 -269.82%
Dec 31, 2021 -648.71%
Sep 30, 2021 17.01%
Jun 30, 2021 -252.10%
Mar 31, 2021 19.51%
Dec 31, 2020 71.40%
Sep 30, 2020 34.12%
Jun 30, 2020 155.82%
Mar 31, 2020 23.95%
Dec 31, 2019 -47.90%
Sep 30, 2019 -100.34%
Jun 30, 2019 5.43%
Mar 31, 2019 -85.14%
Dec 31, 2018 -251.57%
Sep 30, 2018 -5.09%
Jun 30, 2018 -72.30%
Mar 31, 2018 -19.04%
Dec 31, 2017 22.92%
Sep 30, 2017 -0.32%
Jun 30, 2017 -2.88%
Mar 31, 2017 -58.49%
Dec 31, 2016 54.38%
Sep 30, 2016 -6.70%
Jun 30, 2016 26.13%
Mar 31, 2016 37.18%
Dec 31, 2015 -8.21%
Sep 30, 2015 -20.60%
Jun 30, 2015 -79.85%
Mar 31, 2015 -151.31%
Dec 31, 2014 -94.57%
Sep 30, 2014 -247.81%
Jun 30, 2014 -43.09%
Mar 31, 2014 -1.21%
Dec 31, 2013 -41.73%
Sep 30, 2013 11.09%
Jun 30, 2013 8.93%
Mar 31, 2013 24.31%
Dec 31, 2012 29.54%
Sep 30, 2012 43.13%
Jun 30, 2012 -11.03%
Mar 31, 2012 -82.38%
Dec 31, 2011 -66.05%
Sep 30, 2011 -75.89%